Abstract
Several rows of product information in Tables 1 and 2 of the article by Reichel et al.1 were incorrectly captured during production of the article and information therefore appeared in the incorrect columns. The corrected Tables are provided here: 1 TABLE Recombinant follistatins (non-black market products). (Table presented.) *) monomer. The intact protein is a homodimer linked via disulfide-bridges. 2 TABLE Antibodies evaluated for immunoprecipitation and/or Western blotting (Table presented.) Abbreviations: Western blot (WB), Immunoprecipitation (IP), Flow Cytometry (FC).
Cite
CITATION STYLE
Reichel, C., Gmeiner, G., & Thevis, M. (2020, October 1). Erratum to: Detection of black market follistatin 344 (Drug Testing and Analysis, (2019), 11, 11-12, (1675-1697), 10.1002/dta.2741). Drug Testing and Analysis. John Wiley and Sons Ltd. https://doi.org/10.1002/dta.2882
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.